Open AccessSecukinumab's effect on structural damage progression in psoriatic arthritis: longitudinal mixture modelling of FUTURE-1 and FUTURE-5
Author(s) -
Olivier Luttringer,
Todd Fox,
Luminita Pricop,
Corine Gaillez,
Hélène Karcher,
Witold Więcek,
Zuzanna Angehrn,
Billy Amzal
Publication year - 2021
Publication title -
clinical and experimental rheumatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.184
H-Index - 95
eISSN - 1593-098X
pISSN - 0392-856X
DOI - 10.55563/clinexprheumatol/ic89a8
Subject(s) - medicine , secukinumab , placebo , psoriatic arthritis , post hoc analysis , gastroenterology , arthritis , dermatology , surgery , pathology , alternative medicine
Peripheral and axial manifestations of psoriatic arthritis (PsA) can lead to irreversible structural damage and chronic disability. Our objective was to explore predictors of radiographic progression and to increase our understanding of treatment effects in subgroups of patients with different rates of structural damage progression.